bluebird bio’s Skysona Gains FDA Approval to Treat Ultra-Rare Neurological Disorder September 26, 2022
The Financing and Reimbursement of Cures in the US (FoCUS) White Paper Highlights BCS Stop Loss GT Product June 24, 2021
